Prilenia Therapeutics B.V.: Prilenia Plans to Submit Marketi

Prilenia Therapeutics B.V.: Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington's Disease

Prilenia Therapeutics B.V.: Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington's Disease

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , Netherlands , Czech Republic , Morningside , North Lanarkshire , United Kingdom , Israel , Poland , Spain , United States , Italy , Austria , Canada , France , Massachusetts , Stefan Klotter , Michaelr Hayden , Communications Team , Huntington Study Group , Twitter , Sv Health Investors , Linkedin , Adm , Investment Fund , European Medicines Agency , Committee For Medicinal Products Human Use , Drug Administration , European Union , Marketing Authorization Application , Medicinal Products , Human Use , Orphan Drug , Fast Track , Sands Capital , Sectoral Asset Management , Amplitude Ventures , Lassen Sie ,